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Identity 
Other names: LPGP1, Lpgp, MGC21659, S14, 
SPOT14 
HGNC (Hugo): THRSP 
Location: 11q14.1 
Local order: 
According to NCBI Map Viewer, genes flanking 
THRSP in centromere to telomere direction on 11q13 
are:  
PHCA (11q13.5), phytoceramidase, alkaline;  
GDPD4 (11q13.5), glycerophosphate 
phosphodiesterase domain containing 4;  
PAK1 (11q13-14), p21/cdc42/Rac1-activated kinase1 
(STE20 homolog, yeast);  
DFKZp434E1119 (11q14.1), hypothetical protein 
DFKZp434e1119;  
AQP11 (11q14.1), aquaporin 11;  
THRSP;  
LOC646195 (11q14.1), ribosomal protein S28 
pseudogene;  
LOC143543 (11q14.1), RNA binding motif protein X-
linked pseudogene;  
RAB30 (11q12-q14), RAB30, member RAS oncogene 
family;  
PCF11 (11q13), PCF11, cleavage and polyadenylation 
factor subunit, homolog (S. cerevisiae). 
DNA/RNA 
Description 
According to Entrez-Gene, THRSP maps to 
NC_000011.9 in the region between 77774907 and 
77779307 on the plus strand and spans 5.6 kilobases. 
According to Spidey (mRNA to genomic sequence 
alignment tool), THRSP has two exons, the sizes being 
481 and 603 bp. Only the smaller of these is translated. 
Transcription 
THRSP mRNA NM_003251.2 has 1084 nt. The coding 
region of human mRNA for THRSP has 438 nt. 
Transcription is regulated via thyroid hormone and the 
SREBP-1c binding sites. Expression can be induced by 
progestin, glucose, thyroid hormone, and insulin. 
Antisense RNA knocks down S14 expression in 
hepatocytes, and this abrogates the induction of genes 
concerned with fatty acid synthesis by triiodothyronine 
and glucose. 
Pseudogene 
The ancestral S14-related protein, also known as Strait 
11499 and Mig12, may duplicate the function of S14 in 
hepatic, but not mammary, tissue. 
 
An intron (thin line) connects the two exons of THRSP. Most of the 5' exon (thickest line) is translated. 
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Protein 
Note 
THRSP is primarily a nuclear protein which is 
important in the regulation of lipid metabolism. It is 
induced by thyroid hormone, carbohydrate intake, 
adipose tissue differentiation, and lactation, and is 
inhibited by glucagon and conjugated linoleic acid. 
Expression of THRSP (Spot14) parallels that of fatty 
acid synthase in adipose, liver, and mammary tissue in 
bovine and murine species. Elevated expression of 
THRSP in human breast tumors is correlated with poor 
prognosis, whereas absence of expression is associated 
with longer survival. 
Description 
A driver of de novo saturated fatty acid synthesis in 
normal and malignant tissues, Spot14 (S14, THRSP) 
was named for its position on two-dimensional gels of 
in vitro translation products. The gene is rapidly 
induced by thyroid hormone in rat liver, and it is 
strongly activated by glucose metabolism. An acidic 
protein of approximately 16 kD, it is localized 
primarily in the nucleus; three domains are conserved 
from its ancestral protein, Strait1499, also known as 
Mig12 and S14-related protein. 
From immunohistochemical studies, the temporal and 
spatial expression patterns of murine Spot14 and fatty 
acid synthase (FASN) were regulated in parallel in 
mammary epithelium during pregnancy, lactation, and 
involution. In cattle, milk fat depression is associated 
with production of conjugated linoleic acid (CLA) 
isomers as intermediates of fatty acid synthesis by 
rumen bacteria. Ingestion of a low forage, high oil diet 
leads to increased production of CLA, and this results 
in low milk fat content, and decreased expression of 
S14, FASN, sterol response element binding protein 
(SREBP), and responsive genes INSIG1 and INSIG2 in 
a coordinate manner. Breast epithelium does not 
express detectable levels of Spot14 or FASN in the 
resting state; however, during pregnancy and lactation, 
Spot14 and enzymes of lipid biosynthesis are expressed 
at high levels. Spot14 and FASN are expressed in most 
breast cancers, and high levels of Spot14 expression 
portend an aggressive course and high risk of 
recurrence, regardless of nodal status at diagnosis. Thus 
Spot14 represents a potential target for therapeutic 
intervention in cancer. 
Expression 
Spot14 protein is expressed primarily in tissues which 
synthesize fatty acids. These tissues include white and 
brown adipose tissue, breast tissue, and liver. 
Expression is observed in a variety of malignancies, 
and it is a component of the lipogenic tumor phenotype, 
e.g., in human breast cancer. 
Localisation 
By immunohistochemistry, Spot14 is localized 
primarily in the nucleus of rat liver, human mammary 
gland, and breast cancer cells. 
Function 
Spot14 is involved in the regulation of lipid 
biosynthesis. Its precise function is not known. It exists 
as a heterodimer in human cells which are actively 
synthesizing lipids. Triggers for the induction of 
Spot14, such as hormones or refeeding after fasting, 
also trigger FASN activity. Furthermore, siRNAs and 
anti-sense RNAs directed against Spot14 inhibit 
expression of genes coding the lipid-synthesizing 
enzymes. 
Homology 
Homologous proteins are found in cow, rat, mouse, 
chicken, dog, and chimpanzee, as well as other species. 
An acidic protein of approximately 16.4 kDa, human 
THRSP bears 99% homology to its counterpart in Pan 
troglodytes, 91% to that in Macaca mulatta, 82% to that 
in Mus musculus, and 80% to that in Rattus norvegicus 
(data from NCBI BLAST). Three domains are 
conserved from the ancestral S14-related peptide (Strait 
11499, Mig12, S14-related protein). 
Mutations 
Note 
Mutations have been characterized in the chicken. 
Single-nucleotide polymorphisms (SNPs) have been 
noted in cow, rat, mouse, and chimpanzee. The SNP 




Along with cyclin D1, which shares the same amplicon 
at 11q13, S14 is amplified in about 20% of human 
breast cancers. Although cyclin D1 is a human and 
murine mammary oncogene, it was the concomitant 
overexpression of S14 and lipogenic enzymes in 
aggressive breast tumors that prompted investigation of 
the role of fatty acid metabolism in metastasis and 
recurrence of breast tumors. In an 
immunohistochemical study of invasive breast tumors, 
high levels of S14 expression correlated with reduced 
disease-free survival, irrespective of nodal status at 
diagnosis; there were no recurrences among those 
whose tumors expressed low levels of S14, even after 
prolonged follow-up. S14 expression levels did not 
segregate with cyclin D1, Her-2/neu amplification 
status, or hormone receptor status. Thus it appears that 
S14 promotes a virulent, lipogenic phenotype in breast 
tumors. 
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Aberrant hepatic lipogenesis and 
hepatic steatosis 
Note 
The relationship between lipid metabolism and disease 
is further corroborated by the finding in human 
hepatocytes that the pregnane X receptor (PXR), which 
is a nuclear receptor regulating xenobiotic and drug 
metabolism, upregulates lipogenesis via S14. 
Stimulation of PXR also enhances expression of the 
cd36 gene, which permits the uptake of exogenous fatty 
acids by cells, and also stimulates de novo lipogenesis 
as well as upregulation of the enzymes involved in lipid 
synthesis. Knockdown by short interfering RNAs to 
PXR, S14, or FASN abrogates lipid synthesis. S14-
directed fatty acid synthesis has also been implicated in 
aberrant hepatic lipogenesis and hepatic steatosis. 
Obesity 
Note 
It is possible that Spot14 plays a role in the regulation 
of lipid storage in humans. Whereas nonobese humans 
downregulate the level of Spot14 in response to fasting, 
obese subjects do not. Postfasting levels of glucose, 
insulin, and ketones did not differ between the two 
groups. The abnormal downregulation of Spot14 in 
adipose tissue of obese subjects implies that Spot14 
may be important to the acquisition or maintenance of 
obesity in humans. 
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